The Healthcare Businesswomen's Association (HBA) Announces its 2026 Global Board of Directors
Newly elected leaders to guide the HBA’s next chapter by accelerating leadership, connection, and opportunity across the healthcare industry
During the 2025 Annual Business Meeting, the Healthcare Businesswomen’s Association (HBA) announced its 2026 Global Board of Directors.
This accomplished group of global leaders will help steer the HBA’s strategies and priorities, ensuring the association remains focused on advancing its mission and vision. Together, these professionals bring deep expertise, innovative thinking, and a shared commitment to shaping the future of the healthcare industry. The insights and guidance of the 2026 Board of Directors will be essential in driving the association’s strategic direction and fostering connection, development, and impact across HBA’s global network.
The incoming board members were elected through a recent vote by the HBA’s global membership.
2026 HBA Global Board of Directors
Executive Committee:
- Chair: Nicola Greenway, Takeda Pharmaceuticals
- Vice Chair: Wendy Short-Bartie, Bristol Myers Squibb
- Secretary/Treasurer: Sandra Forero, ZS
- HBA CEO: Mary Stutts*
Directors at Large:
- Tanya Alcorn, Pfizer
- Dianne Auclair Rocha, Novartis
- Ramcess Jean-Louis, Pfizer
- Adam Dubow, Day One Biopharmaceuticals
- Victoria Williams, GSK
- Deborah Lancaster, KPMG
- Dr. Deepa Desai, D Cube Consultancy
- Preety Sidhu Adler, Cardinal Health
- Tamika Jean-Baptiste, Amgen*
- Giles Platford, Takeda Pharmaceuticals*
- Kathryn B. Becker, Abbott – NA Operating Board President*
- Sandra Orta, BMS – EMEA Operating Board President*
- Aparna Paluri, Accenture – APAC Operating Board President*
2026 HBA Nominating Committee
- Chair: Julie Ross, Advanced Clinical
- Marie-Caroline Chauvet, Insigniam
- Winston Kirton, BakerHostetler LLP
- Dianne Yurek, Scale Health
- Andrea Henderson, DHR Global
As the new Board and Nominating Committee prepare to begin their terms, the HBA extends its sincere gratitude to the 2025 Global Board of Directors and the 2025 Nominating Committee for their service and leadership.
A special thank you to the leaders who are completing their 2025 appointments:
- Andrea Loewendorf, UCB
- Kristen Von Seggern
- Judy Kannenberg, Kannenberg Coaching & Consulting, LLC
Looking Ahead
With this talented and dedicated team at the helm, the HBA is well-positioned to continue driving meaningful impact and nurturing the next generation of leaders across the global healthcare industry. The 2026 Board’s vision and collaboration will guide the organization toward new opportunities, innovative initiatives, and continued success in fulfilling its mission.
*Non-voting Director-at-Large